Prospective Trial on Tolerability and Efficacy of Adjuvant Nedaplatin Plus Docetaxel for Non-Small Cell Lung Cancer
{{output}}
Nedaplatin is a second-generation platinum compound with reduced nephrotoxicity compared with cisplatin. Given its favorable tolerability in advanced non-small cell lung cancer (NSCLC), we prospectively evaluated the tolerability and efficacy of an adjuvant ne... ...